ErbB3 has been identified as a key partner for ErbB2, with this receptor heterodimer being identified as an oncogenic unit in breast cancer cells [37], whilst overexpression of ErbB4 has also been shown to promote growth of human breast cancer cells [38,39]. Here, ERBB4 is linked to breast cancer.